159 related articles for article (PubMed ID: 16574448)
1. Bayesian-regularized genetic neural networks applied to the modeling of non-peptide antagonists for the human luteinizing hormone-releasing hormone receptor.
Fernández M; Caballero J
J Mol Graph Model; 2006 Dec; 25(4):410-22. PubMed ID: 16574448
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements of pyrido[2,3-d]pyrimidin-7-one as CDK4/D inhibitors: 2D autocorrelation, CoMFA and CoMSIA analyses.
Caballero J; Fernández M; González-Nilo FD
Bioorg Med Chem; 2008 Jun; 16(11):6103-15. PubMed ID: 18468903
[TBL] [Abstract][Full Text] [Related]
3. Modeling of activity of cyclic urea HIV-1 protease inhibitors using regularized-artificial neural networks.
Fernández M; Caballero J
Bioorg Med Chem; 2006 Jan; 14(1):280-94. PubMed ID: 16202604
[TBL] [Abstract][Full Text] [Related]
4. 2D Autocorrelation modeling of the negative inotropic activity of calcium entry blockers using Bayesian-regularized genetic neural networks.
Caballero J; Garriga M; Fernández M
Bioorg Med Chem; 2006 May; 14(10):3330-40. PubMed ID: 16442799
[TBL] [Abstract][Full Text] [Related]
5. Ensembles of Bayesian-regularized genetic neural networks for modeling of acetylcholinesterase inhibition by huprines.
Fernández M; Caballero J
Chem Biol Drug Des; 2006 Oct; 68(4):201-12. PubMed ID: 17105484
[TBL] [Abstract][Full Text] [Related]
6. QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.
Fernández M; Caballero J
Bioorg Med Chem; 2007 Sep; 15(18):6298-310. PubMed ID: 17590339
[TBL] [Abstract][Full Text] [Related]
7. QSAR models for predicting the activity of non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists derived from erythromycin A using quantum chemical properties.
Fernández M; Caballero J
J Mol Model; 2007 Apr; 13(4):465-76. PubMed ID: 17216287
[TBL] [Abstract][Full Text] [Related]
8. 2D autocorrelation modelling of the inhibitory activity of cytokinin-derived cyclin-dependent kinase inhibitors.
González MP; Caballero J; Helguera AM; Garriga M; González G; Fernández M
Bull Math Biol; 2006 May; 68(4):735-51. PubMed ID: 16802081
[TBL] [Abstract][Full Text] [Related]
9. Proteochemometric modeling of the inhibition complexes of matrix metalloproteinases with N-hydroxy-2-[(phenylsulfonyl)amino]acetamide derivatives using topological autocorrelation interaction matrix and model ensemble averaging.
Fernández M; Fernández L; Caballero J; Abreu JI; Reyes G
Chem Biol Drug Des; 2008 Jul; 72(1):65-78. PubMed ID: 18554254
[TBL] [Abstract][Full Text] [Related]
10. Artificial neural networks from MATLAB in medicinal chemistry. Bayesian-regularized genetic neural networks (BRGNN): application to the prediction of the antagonistic activity against human platelet thrombin receptor (PAR-1).
Caballero J; Fernández M
Curr Top Med Chem; 2008; 8(18):1580-605. PubMed ID: 19075769
[TBL] [Abstract][Full Text] [Related]
11. Linear and nonlinear modeling of antifungal activity of some heterocyclic ring derivatives using multiple linear regression and Bayesian-regularized neural networks.
Caballero J; Fernández M
J Mol Model; 2006 Jan; 12(2):168-81. PubMed ID: 16205958
[TBL] [Abstract][Full Text] [Related]
12. QSAR study of malonyl-CoA decarboxylase inhibitors using GA-MLR and a new strategy of consensus modeling.
Li J; Lei B; Liu H; Li S; Yao X; Liu M; Gramatica P
J Comput Chem; 2008 Dec; 29(16):2636-47. PubMed ID: 18484640
[TBL] [Abstract][Full Text] [Related]
13. Amino Acid Sequence Autocorrelation vectors and ensembles of Bayesian-Regularized Genetic Neural Networks for prediction of conformational stability of human lysozyme mutants.
Caballero J; Fernández L; Abreu JI; Fernández M
J Chem Inf Model; 2006; 46(3):1255-68. PubMed ID: 16711745
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor.
Sasaki S; Cho N; Nara Y; Harada M; Endo S; Suzuki N; Furuya S; Fujino M
J Med Chem; 2003 Jan; 46(1):113-24. PubMed ID: 12502365
[TBL] [Abstract][Full Text] [Related]
15. Linear and nonlinear QSAR study of N-hydroxy-2-[(phenylsulfonyl)amino]acetamide derivatives as matrix metalloproteinase inhibitors.
Fernández M; Caballero J; Tundidor-Camba A
Bioorg Med Chem; 2006 Jun; 14(12):4137-50. PubMed ID: 16504515
[TBL] [Abstract][Full Text] [Related]
16. Modeling of cyclin-dependent kinase inhibition by 1H-pyrazolo[3,4-d]pyrimidine derivatives using artificial neural network ensembles.
Fernández M; Tundidor-Camba A; Caballero J
J Chem Inf Model; 2005; 45(6):1884-95. PubMed ID: 16309296
[TBL] [Abstract][Full Text] [Related]
17. Modeling of acetylcholinesterase inhibition by tacrine analogues using Bayesian-regularized Genetic Neural Networks and ensemble averaging.
Fernández M; Carreiras MC; Marco JL; Caballero J
J Enzyme Inhib Med Chem; 2006 Dec; 21(6):647-61. PubMed ID: 17252937
[TBL] [Abstract][Full Text] [Related]
18. A self-adaptive genetic algorithm-artificial neural network algorithm with leave-one-out cross validation for descriptor selection in QSAR study.
Wu J; Mei J; Wen S; Liao S; Chen J; Shen Y
J Comput Chem; 2010 Jul; 31(10):1956-68. PubMed ID: 20512843
[TBL] [Abstract][Full Text] [Related]
19. Generation of QSAR sets with a self-organizing map.
Guha R; Serra JR; Jurs PC
J Mol Graph Model; 2004 Sep; 23(1):1-14. PubMed ID: 15331049
[TBL] [Abstract][Full Text] [Related]
20. Application of ab initio theory to QSAR study of 1,4-dihydropyridine-based calcium channel blockers using GA-MLR and PC-GA-ANN procedures.
Hemmateenejad B; Safarpour MA; Miri R; Taghavi F
J Comput Chem; 2004 Sep; 25(12):1495-503. PubMed ID: 15224393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
